Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid-containing regimen for tuberculous meningitis
ChiCTR2300076246Phase 4Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of linezolid in meningeal tuberculosis (2 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoint: Mortality at end of treatment. Started May 2022; status: recruiting.
02
Drugs
linezolid
03
Conditions
meningeal tuberculosis
Beyond the preview
Go deeper on ChiCTR2300076246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076246.